Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
1970-01-01 08:00
British Gas Owner Boosts Shareholder Returns: The London Rush
Centrica is boosting shareholder returns after profit at its British Gas business increased almost 10-fold compared to last
1970-01-01 08:00
Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
1970-01-01 08:00
European Stocks Extend First-Half Rally as Cyclicals Advance
European stocks extended gains on Monday, led by cyclical sectors, as signs of cooling US inflation fueled appetite
1970-01-01 08:00
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
1970-01-01 08:00
AstraZeneca to Fight Deforestation With 200 Million Trees: The London Rush
AstraZeneca is putting its money where its mouth is when it comes to fighting climate change and biodiversity
1970-01-01 08:00
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
1970-01-01 08:00
Sanofi Cuts Zantac Exposure With Arbitration Win Over Boehringer
Sanofi defeated Boehringer Ingelheim GmbH in an arbitration proceeding over legal responsibilities tied to controversial heartburn medicine Zantac.
1970-01-01 08:00
Only Labour Can Fix the NHS, Says Boris Johnson’s Vaccine Czar
The National Health Service is “hopeless” and needs a “complete restructuring,” says the woman behind one of its
1970-01-01 08:00
Pan-African Approach Needed to Ensure Food Security: New Economy
A pan-African approach is needed to solve the continent’s food-security dilemma given the high cost of developing agricultural
1970-01-01 08:00
Britain’s Post-Brexit Policy Drift Alarms World’s Executives
When Dan Vahdat set out to build a healthcare startup, the UK was an ideal launchpad. That was
1970-01-01 08:00
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
1970-01-01 08:00